Literature DB >> 31012056

Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome.

Joseph R Geraghty1,2, Joseph L Davis3, Fernando D Testai3.   

Abstract

Aneurysmal subarachnoid hemorrhage has a high mortality rate and, for those who survive this devastating injury, can lead to lifelong impairment. Clinical trials have demonstrated that cerebral vasospasm of larger extraparenchymal vessels is not the sole contributor to neurological outcome. Recently, the focus of intense investigation has turned to mechanisms of early brain injury that may play a larger role in outcome, including neuroinflammation and microvascular dysfunction. Extravasated blood after aneurysm rupture results in a robust inflammatory response characterized by activation of microglia, upregulation of cellular adhesion molecules, recruitment of peripheral immune cells, as well as impaired neurovascular coupling, disruption of the blood-brain barrier, and imbalances in endogenous vasodilators and vasoconstrictors. Each of these phenomena is either directly or indirectly associated with neuronal death and brain injury. Here, we review recent studies investigating these various mechanisms in experimental models of subarachnoid hemorrhage with special emphasis on neuroinflammation and its effect on microvascular dysfunction. We discuss the various therapeutic targets that have risen from these mechanistic studies and suggest the utility of a multi-targeted approach to preventing delayed injury and improving outcome after subarachnoid hemorrhage.

Entities:  

Keywords:  Early brain injury; Microvascular dysfunction; Neuroinflammation; Subarachnoid hemorrhage; Vasospasm

Mesh:

Substances:

Year:  2019        PMID: 31012056      PMCID: PMC6759381          DOI: 10.1007/s12028-019-00710-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  181 in total

Review 1.  Aneurysmal subarachnoid hemorrhage.

Authors:  Jose I Suarez; Robert W Tarr; Warren R Selman
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

2.  Long-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage: Patients With Multiple Aneurysms at Risk.

Authors:  Justiina Huhtakangas; Hanna Lehto; Karri Seppä; Riku Kivisaari; Mika Niemelä; Juha Hernesniemi; Martin Lehecka
Journal:  Stroke       Date:  2015-06-04       Impact factor: 7.914

3.  Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage.

Authors:  R Webster Crowley; R Medel; Aaron S Dumont; Don Ilodigwe; Neal F Kassell; Stephan A Mayer; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Stroke       Date:  2011-02-24       Impact factor: 7.914

4.  Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group.

Authors:  Mervyn D I Vergouwen; Marinus Vermeulen; Jan van Gijn; Gabriel J E Rinkel; Eelco F Wijdicks; J Paul Muizelaar; A David Mendelow; Seppo Juvela; Howard Yonas; Karel G Terbrugge; R Loch Macdonald; Michael N Diringer; Joseph P Broderick; Jens P Dreier; Yvo B W E M Roos
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

5.  Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.

Authors:  Marianna Pegoli; Jay Mandrekar; Alejandro A Rabinstein; Giuseppe Lanzino
Journal:  J Neurosurg       Date:  2014-12-12       Impact factor: 5.115

6.  The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States.

Authors:  Fred Rincon; Robert H Rossenwasser; Aaron Dumont
Journal:  Neurosurgery       Date:  2013-08       Impact factor: 4.654

7.  Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Authors:  R Loch Macdonald; Neal F Kassell; Stephan Mayer; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Aline Frey; Sebastien Roux; Alberto Pasqualin
Journal:  Stroke       Date:  2008-08-07       Impact factor: 7.914

8.  Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage.

Authors:  J P Broderick; T G Brott; J E Duldner; T Tomsick; A Leach
Journal:  Stroke       Date:  1994-07       Impact factor: 7.914

Review 9.  Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology.

Authors:  Joseph R Geraghty; Fernando D Testai
Journal:  Curr Atheroscler Rep       Date:  2017-10-23       Impact factor: 5.113

10.  A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects.

Authors:  N W Dorsch; M T King
Journal:  J Clin Neurosci       Date:  1994-01       Impact factor: 1.961

View more
  32 in total

Review 1.  Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Histol Histopathol       Date:  2020-02-06       Impact factor: 2.303

Review 2.  Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury.

Authors:  Michael L James; Jordan M Komisarow; Haichen Wang; Daniel T Laskowitz
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

Review 3.  Emerging Role of Microglia-Mediated Neuroinflammation in Epilepsy after Subarachnoid Hemorrhage.

Authors:  Jingxue Liang; Jiahong Deng; Xiaolin Liang; Jun Wang; Kewan Wang; Hongxiao Wang; Dadi Qian; Hao Long; Kaijun Yang; Songtao Qi
Journal:  Mol Neurobiol       Date:  2021-01-26       Impact factor: 5.590

Review 4.  Unpacking the Role of Extracellular Vesicles in Ischemic and Hemorrhagic Stroke: Pathophysiology and Therapeutic Implications.

Authors:  Yonatan Hirsch; Joseph R Geraghty; Cory R Reiter; Eitan A Katz; Conner F Little; Matthew K Tobin; Fernando D Testai
Journal:  Transl Stroke Res       Date:  2022-05-06       Impact factor: 6.829

5.  Targeting iNOS Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage via Promoting Ferroptosis of M1 Microglia and Reducing Neuroinflammation.

Authors:  Wenhao Qu; Ying Cheng; Wei Peng; Yan Wu; Tongyu Rui; Chengliang Luo; Jian Zhang
Journal:  Mol Neurobiol       Date:  2022-03-09       Impact factor: 5.590

6.  Severe cognitive impairment in aneurysmal subarachnoid hemorrhage: Predictors and relationship to functional outcome.

Authors:  Joseph R Geraghty; Melissa N Lara-Angulo; Milen Spegar; Jenna Reeh; Fernando D Testai
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-06-20       Impact factor: 2.136

Review 7.  Aneurysmal Subarachnoid Hemorrhage: an Overview of Inflammation-Induced Cellular Changes.

Authors:  A P Coulibaly; J J Provencio
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

8.  A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Ross P Martini; Dominic Siler; Justin Cetas; Nabil J Alkayed; Elyse Allen; Miriam M Treggiari
Journal:  Neurocrit Care       Date:  2021-12-06       Impact factor: 3.210

Review 9.  Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Hidenori Suzuki; Hideki Kanamaru; Fumihiro Kawakita; Reona Asada; Masashi Fujimoto; Masato Shiba
Journal:  Histol Histopathol       Date:  2020-09-30       Impact factor: 2.303

Review 10.  Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).

Authors:  Judith Weiland; Alexandra Beez; Thomas Westermaier; Ekkehard Kunze; Anna-Leena Sirén; Nadine Lilla
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.